MEMBER
INVESTMENT PROFESSIONAL
Principal
AZUSA SHIOHARA
- PROFILE
- CAREER
- MEDIA/PUBLICATION
● Azusa joined UTEC in September 2021.
● She focuses on seed/early-stage biotech/healthcare investments.
● Prior to joining UTEC, she worked as a manager of the biotech/healthcare team at Arthur D Little, a global management consulting firm. At Arthur D Little, she had a particular focus on cutting edge biotechnology-enabled businesses, supporting her clients with new business development, R&D and other management issues.
● She holds an MBA from London Business School and an MSc in Pharmaceutical Sciences from the University of Tokyo.
● She focuses on seed/early-stage biotech/healthcare investments.
● Prior to joining UTEC, she worked as a manager of the biotech/healthcare team at Arthur D Little, a global management consulting firm. At Arthur D Little, she had a particular focus on cutting edge biotechnology-enabled businesses, supporting her clients with new business development, R&D and other management issues.
● She holds an MBA from London Business School and an MSc in Pharmaceutical Sciences from the University of Tokyo.
Azusa has experience as a management consultant at Arthur D Little, a global management consulting firm.
Azusa holds an MBA from London Business School and a BA and MSc in Pharmaceutical Sciences from the University of Tokyo.
Azusa holds an MBA from London Business School and a BA and MSc in Pharmaceutical Sciences from the University of Tokyo.
Nikkei Biotech: A road map for commercialization of regenerative and cell therapy
Nikkei Biotech: World Trend Europe